Skip to main content
    E

    Evolent Health Inc (EVH)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $4.88
    +0.15 (+3.17%)

    Market Cap: $520.07M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(26/39)
    Avg Surprise
    +185.19%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.06
    Range$0.01 - $0.09
    9 analysts
    EPS Revisions
    1
    0
    7d
    5
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$0.05+12.1%
    60d ago$0.04+45.6%
    30d ago$0.06-0.2%
    7d ago$0.060.0%
    Current$0.06
    Revenue Consensus
    $727M
    Range$687M - $755M
    14 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.20
    Range$0.10 - $0.27
    9 analysts
    Revenue Consensus
    $774M
    Range$700M - $809M
    14 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.20---
    Sep 26EST
    		-$0.06---
    Jun 26
    Reported Aug 6
    		$-0.11$-0.10-10.00%Miss+35.3%
    Mar 26
    Reported May 7
    		$-0.02N/A-136.83%Miss-133.3%
    Dec 25
    Reported Feb 24
    		$0.08$0.05+60.00%Beat+500.0%
    Sep 25
    Reported Nov 6
    		$0.05$0.10-50.00%Miss+25.0%
    Jun 25
    Reported Aug 7
    		$-0.17$0.08-312.50%Miss-156.7%
    Mar 25
    Reported May 8
    		$0.06$0.10-40.00%Miss-82.4%
    Dec 24
    Reported Feb 20
    		$-0.02$0.01-260.00%Miss-108.7%
    Sep 24
    Reported Nov 7
    		$0.04N/A-88.24%Miss-86.7%
    Jun 24
    Reported Aug 8
    		$0.30$0.25+20.00%Beat+114.3%
    Mar 24
    Reported May 9
    		$0.34$0.30+13.33%Beat+61.9%
    Dec 23
    Reported Feb 22
    		$0.23$0.15+53.33%Beat+130.0%
    Sep 23
    Reported Nov 2
    		$0.30$0.10+200.00%Beat-49.2%
    Jun 23
    Reported Aug 2
    		$0.14$0.15-6.67%Miss+40.0%
    Mar 23
    Reported May 3
    		$0.21$0.19+10.53%Beat+75.0%
    Dec 22
    Reported Feb 22
    		$0.10$0.16-37.50%Miss+25.0%
    Sep 22
    Reported Nov 2
    		$0.59$0.10+490.00%Beat+2066.7%
    Jun 22
    Reported Aug 2
    		$0.10$0.05+100.00%Beat+600.0%
    Mar 22
    Reported May 4
    		$0.12$-0.00+6100.00%Beat+1300.0%
    Dec 21
    Reported Feb 23
    		$0.08$0.01+700.00%Beat+900.0%
    Sep 21
    Reported Nov 3
    		$-0.03$-0.03+0.00%Beat+0.0%
    Jun 21
    Reported Aug 4
    		$-0.02$-0.03+33.33%Beat+33.3%
    Mar 21
    Reported May 5
    		$-0.01N/A+85.71%Beat+92.9%
    Dec 20
    Reported Feb 25
    		$-0.01N/A+80.00%Beat+85.7%
    Sep 20
    Reported Nov 5
    		$-0.03$-0.05+40.00%Beat+66.7%
    Jun 20
    Reported Aug 4
    		$-0.03N/A+70.00%Beat+88.5%
    Mar 20
    Reported May 7
    		$-0.14$-0.13-7.69%Miss+54.8%
    Dec 19
    Reported Feb 25
    		$-0.07$-0.04-75.00%Miss+0.0%
    Sep 19
    Reported Nov 5
    		$-0.09$-0.12+25.00%Beat-125.0%
    Jun 19
    Reported Aug 6
    		$-0.26$-0.23-13.04%Miss-766.7%
    Mar 19
    Reported May 7
    		$-0.31$-0.33+6.06%Beat-1650.0%
    Dec 18
    Reported Feb 26
    		$-0.07$-0.04-75.00%Miss-75.0%
    Sep 18
    Reported Nov 6
    		$-0.04$-0.04+0.00%Beat+0.0%
    Jun 18
    Reported Aug 7
    		$-0.03$-0.04+25.00%Beat+76.9%
    Mar 18
    Reported May 9
    		$0.02$-0.04+150.00%Beat+114.3%
    Dec 17
    Reported Feb 27
    		$-0.04$-0.04+0.00%Beat+77.8%
    Sep 17
    Reported Nov 2
    		$-0.04$-0.08+50.00%Beat-
    Jun 17
    Reported Aug 7
    		$-0.13$-0.13+0.00%Beat-
    Mar 17
    Reported May 9
    		$-0.14$-0.16+12.50%Beat-
    Dec 16
    Reported Feb 28
    		$-0.18$-0.20+10.00%Beat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF22.57xFCF Yield4.43%
    Profitability
    Profit Margin-24.10%Operating Margin-1.34%
    ROE-67.00%ROIC-31.65%
    Financial Health
    Debt/Equity2.52xInterest Coverage-5.43x
    Current Ratio1.24xQuick Ratio1.24x
    Trading Statistics
    Beta1.02Avg Volume2.24M
    52-Week High$8.3052-Week Low$2.10

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.15
    SMA 20$3.87
    SMA 50$4.14
    SMA 200$3.84
    EMA 10$4.28
    EMA 20$4.10
    EMA 50$4.12
    EMA 200$4.53

    MACD

    Line: 0.15Signal: -0.02Hist: 0.16

    ADX

    ADX: 31.6+DI: 37.9-DI: 9.9

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down64.0
    PSAR$3.76

    Bollinger Bands

    Upper Band$4.75
    Lower Band$3.00
    %B Position4526%(Upper)
    Band Width1.07

    RSI (14-Day)

    Overbought
    71.4

    Momentum Oscillators

    Stoch %K92.3
    Stoch %D93.6
    Williams %R-13.1
    ROC (10d)44.0%
    Momentum1.49
    CCI (20d)212.2
    MFI (14d)71.8

    Volatility Measures

    ATR (14d)$0.27(5.6%)
    StdDev (20d)0.44
    Hist Vol61.4%(High)

    Volume Flow

    VWAP$4.92
    OBV-28.7M
    AD Line-66.7M
    CMF (20d)0.193

    Volume Metrics

    Avg Vol (20d)2.2M
    Vol Ratio1.8x(High)
    VWMA (20d)$3.92

    Pivot Points

    R3$5.11
    R2$4.93
    R1$4.83
    Pivot Point$4.66
    S1$4.56
    S2$4.38
    S3$4.28

    Advanced Oscillators

    TSI15.55
    Ultimate Osc65.8
    KST-8.83

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$652.52M$496.25M$468.72M$479.53M$444.33M$483.65M$646.54M$621.40M$647.14M$639.65M$556.05M$511.01M
    Cost of Revenue$571.68M$412.47M$371.47M$379.76M$343.94M$381.18M$570.83M$540.71M$540.30M$535.55M$454.43M$386.58M
    Gross Profit$80.84M$83.77M$97.25M$99.77M$100.39M$102.47M$75.71M$80.69M$106.84M$104.11M$101.63M$124.43M
    Operating Expenses$90.40M$94.37M$505.48M$98.89M$101.56M$104.09M$94.31M$96.96M$99.06M$117.52M$122.98M$142.37M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$68.83M$72.82M$72.66M$77.59M$75.21M$78.41M$47.70M$67.06M$69.19M$79.10M$81.43M$96.57M
    Operating Income$-9,561,000$-10,599,000$-408,231,000$886,000$-1,171,000$-1,622,000$-18,596,000$-16,268,000$7.79M$-13,409,000$-21,350,000$-17,938,000
    Interest Income$662,000$1.00M$899,000$1.12M$1.28M$1.25M$1.01M$-1,435,000$-330,000$2.86M$2.55M$1.75M
    Interest Expense$16.86M$16.87M$22.92M$22.04M$20.60M$10.38M$6.72M$6.01M$6.00M$6.00M$33.25M$14.61M
    Income Before Tax$-25,649,000$-25,722,000$-430,808,000$-19,958,000$-20,722,000$-63,148,000$-23,923,000$-23,756,000$1.36M$-16,715,000$-48,067,000$-30,874,000
    Income Tax Expense$2.71M$910,000$-1,677,000$906,000$-825,000$1.47M$-1,121,000$-619,000$-238,000$565,000$-14,656,000$-5,550,000
    Net Income$-28,364,000$-26,632,000$-429,131,000$-20,864,000$-19,897,000$-64,618,000$-22,802,000$-23,137,000$1.60M$-17,280,000$-33,411,000$-25,324,000
    EBITDA$16.19M$15.58M$-359,614,000$30.12M$24.27M$-27,569,000$13.17M$15.56M$39.55M$18.02M$16.07M$17.72M
    EBIT$-9,452,000$-9,857,000$-408,783,000$966,000$-1,402,000$-54,018,000$-18,215,000$-16,311,000$7.68M$-13,574,000$-17,368,000$-18,015,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about EVH

    News

    EVH | Evolent Health, Inc Class Financials - Revenue Breakdown

    This article provides a financial overview of Evolent Health, Inc. (EVH), including its revenue breakdown, Congressional trading activity, and insider trading information. It also details the company's business model...

    Quiver Quantitative•8/23/26•Neutral

    Evolent Health (EVH) Stock Rebounds As Growth Momentum Confronts Losses

    Evolent Health (EVH) stock jumped 10% after its Q2 report, showcasing significant revenue growth despite persistent net losses. The company's future hinges on balancing its multi-year revenue expansion from Performance...

    Sahm•8/8/26•Neutral

    Tempus AI ( TEM ) Reports Q2 Loss, Beats Revenue Estimates

    Tempus (TEM) delivered earnings and revenue surprises of +69.23% and +0.40%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Commentary•7/30/26•Neutral

    Philips Q2 Earnings and Revenues Increase Year over Year, Shares Down

    PHG lifts its 2026 profit and free cash flow outlook after Q2 earnings increase on higher sales, productivity gains and a U.S. tariff refund benefit.

    Zacks Commentary•7/29/26•Neutral

    Evolent Health Inc Class A (EVH) Stock Price | Live Quotes & Charts | NYSE

    This page provides live stock quotes and charts for Evolent Health Inc Class A (EVH) on the NYSE, showing a current price of $4.26 and an 8.19% decrease. It also notes the absence of analyst ratings or earnings...

    timothysykes.com•7/21/26•Bearish

    EVH Valuation and Fair Value

    Forward P/E
    8.6x
    P/FCF
    22.6x
    PEG
    1.9x
    P/B
    1.4x
    See GNG's fair value

    EVH Profitability: Margins, ROIC and FCF

    Gross margin
    17.2%
    Operating margin
    -1.3%
    Net margin
    -24.1%
    ROIC
    -31.6%
    ROE
    -67.0%
    FCF margin
    1.2%
    FCF yield
    4.4%

    EVH Competitors

    CompanyTicker
    Puma Biotechnology IncPBYI
    Oncology Institute IncTOI
    Shattuck Labs IncSTTK
    Delcath Systems IncDCTH
    Bright Minds Biosciences IncDRUG
    CytomX Therapeutics IncCTMX
    ZimVie IncZIMV
    Tactile Systems Technology IncTCMD

    Sector: Healthcare

    EVH Analyst Ratings

    Consensus
    Buy
    Analysts
    14
    Strong Buy
    4
    Buy
    7
    Hold
    3
    Sell
    0
    Strong Sell
    0

    EVH Bull Case vs Bear Case

    Bull case

    • EVH grew quarterly revenue 46.9% year over year.
    • 78.6% of EVH's analyst ratings are Buy or Strong Buy.

    Bear case

    • EVH has a -24.1% net profit margin.
    • EVH beat EPS estimates in 12.5% of its last 8 reported quarters.
    • EVH has a debt-to-equity ratio of 2.5x.

    EVH Earnings: Beat Rate and Next Report

    Beat rate
    1 of 8 quarters (12.5%)
    Average surprise
    -104.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.06
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    5 up, 3 down

    Frequently Asked Questions About EVH

    Does EVH pay dividends?

    Evolent Health Inc (EVH) does not currently pay a regular dividend.

    What is EVH's market cap?

    Evolent Health Inc (EVH) has a market capitalization of $520.07M with a current stock price of $4.88.

    Related stocks

    Sector: Healthcare

    All stocks starting with E

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In